Sionna Therapeutics, Inc.
SION
$17.35
$1.519.53%
NASDAQ
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 54.41% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 8.42% | ||||
| Operating Income | -8.42% | ||||
| Income Before Tax | -4.00% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -4.00% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -4.00% | ||||
| EBIT | -8.42% | ||||
| EBITDA | -8.54% | ||||
| EPS Basic | 81.66% | ||||
| Normalized Basic EPS | 81.66% | ||||
| EPS Diluted | 81.66% | ||||
| Normalized Diluted EPS | 81.66% | ||||
| Average Basic Shares Outstanding | 466.95% | ||||
| Average Diluted Shares Outstanding | 466.95% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||